These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 34998385)
41. Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601 [TBL] [Abstract][Full Text] [Related]
42. PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer. Yin L; Shi J; Zhang J; Lin X; Jiang W; Zhu Y; Song Y; Lu Y; Ma Y Sci Rep; 2023 Dec; 13(1):22243. PubMed ID: 38097666 [TBL] [Abstract][Full Text] [Related]
43. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
44. DFNA5 regulates immune cells infiltration and exhaustion. Hu J; Pei W; Jiang M; Huang Y; Dong F; Jiang Z; Xu Y; Li Z Cancer Cell Int; 2022 Mar; 22(1):107. PubMed ID: 35248047 [TBL] [Abstract][Full Text] [Related]
45. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453 [TBL] [Abstract][Full Text] [Related]
46. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer. Yang WJ; Shi L; Wang XM; Yang GW Aging (Albany NY); 2021 Aug; 13(16):20836-20852. PubMed ID: 34461608 [TBL] [Abstract][Full Text] [Related]
47. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021 [TBL] [Abstract][Full Text] [Related]
48. Prognostic and immunological role of Fam20C in pan-cancer. Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121 [TBL] [Abstract][Full Text] [Related]
49. Prognostic Value of Gastrokine-2 (GKN2) and Its Correlation with Tumor-Infiltrating Immune Cells in Lung Cancer and Gastric Cancers. Liu F; Wu H J Inflamm Res; 2020; 13():933-944. PubMed ID: 33235482 [TBL] [Abstract][Full Text] [Related]
50. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169 [TBL] [Abstract][Full Text] [Related]
51. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma. Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148 [No Abstract] [Full Text] [Related]
52. Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma. He J; Gao R; Meng M; Yu M; Liu C; Li J; Song Y; Wang H Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769557 [TBL] [Abstract][Full Text] [Related]
53. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration. Hu K; Yao L; Yan Y; Zhou L; Li J Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675 [TBL] [Abstract][Full Text] [Related]
54. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma. Hu Y; Liu Y; Ma C; Ai K Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082 [TBL] [Abstract][Full Text] [Related]
55. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity. Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089 [TBL] [Abstract][Full Text] [Related]
56. Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma. Ma W; Liang J; Mo J; Zhang S; Hu N; Tian D; Chen Z BMC Cancer; 2021 Oct; 21(1):1096. PubMed ID: 34635082 [TBL] [Abstract][Full Text] [Related]
57. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y Front Oncol; 2020; 10():553297. PubMed ID: 33614473 [TBL] [Abstract][Full Text] [Related]
58. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker. Feng Z; Chen Y; Cai C; Tan J; Liu P; Chen Y; Shen H; Zeng S; Han Y Front Immunol; 2022; 13():916594. PubMed ID: 35844598 [TBL] [Abstract][Full Text] [Related]
59. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
60. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Zhang Z; Wang Z; Liu Y; Zhao L; Fu W J Environ Pathol Toxicol Oncol; 2023; 42(2):11-30. PubMed ID: 36749087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]